How much funding has Octant raised?

Octant has raised $114.9M in total funding, most recently a Grant round.

Who are Octant's investors?

Octant's investors include Andreessen Horowitz, Catalio Capital Management, Bristol Myers Squibb, 8VC, SV Angel.

Where is Octant headquartered?

Octant is headquartered in South San Francisco, California, United States.

What industry is Octant in?

Octant operates in Biotech, Drug Discovery, Life Sciences.

Octant

Novel therapeutics for serious diseases

South San Francisco, United States · Founded 2019 · $114.9M raised

Biotech

Drug Discovery

Life Sciences

Headquarters: South San Francisco, California
Employees: 51–200
Founded: 2019
Business Model: B2B

Total Funding: $114.9M
Last Round: $4.9M GrantJun 2025
Rounds: 3

About

Octant is a therapeutics company pioneering a new type of small molecule drug discovery by using massive experimentation in human cells via its Navigator platform, which integrates synthetic biology, high-throughput chemistry, and AI/ML. The platform models how target proteins interact within cells — including signaling, transcription, and trafficking — rather than simply binding isolated proteins. Octant focuses on rare diseases and oncology driven by protein misfolding.

Summary

Octant is a Biotech company based in South San Francisco, United States, founded in 2019. It has raised $114.9M in total across 3 rounds, most recently a $4.9M Grant round in Jun 2025. Investors include Andreessen Horowitz, Catalio Capital Management and Bristol Myers Squibb.

X (Twitter)